Literature DB >> 31701184

Glomerulonephritis and Coombs-positive hemolytic anemia mimicking scleroderma renal crisis in an overlap of systemic lupus erythematosus and diffuse systemic sclerosis.

Ali Taylan1, Emel Tekin2, Bahar Engin3.   

Abstract

Systemic sclerosis (SSc) may overlap frequently with other rheumatic diseases, including systemic lupus erythematosus (SLE), which can require high-dose steroids depending on the clinical presentation. We present a case involving this overlap in which the patient concomitantly developed lupus nephritis and Coombs (+) hemolytic anemia, which was confused with scleroderma renal crisis. In this condition, assessing for lupus nephritis with timely renal biopsy and lupus serology can aid in guiding the appropriate treatment. We discuss the clinical features and challenging management of this case with a review of the English-language literature for SSc and SLE overlap with glomerulonephritis.

Entities:  

Keywords:  Glomerulonephritis; Hemolytic anemia; Scleroderma renal crisis; Systemic sclerosis and systemic lupus erythematosus overlap

Mesh:

Year:  2019        PMID: 31701184     DOI: 10.1007/s00296-019-04471-w

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  20 in total

Review 1.  'Overlap' syndromes.

Authors:  R Cervera; M A Khamashta; G R Hughes
Journal:  Ann Rheum Dis       Date:  1990-11       Impact factor: 19.103

Review 2.  Scleroderma renal crisis.

Authors:  Marie Hudson
Journal:  Curr Opin Rheumatol       Date:  2015-11       Impact factor: 5.006

Review 3.  Corticosteroids and the risk of scleroderma renal crisis: a systematic review.

Authors:  Gerald Trang; Russell Steele; Murray Baron; Marie Hudson
Journal:  Rheumatol Int       Date:  2010-12-04       Impact factor: 2.631

4.  Combination therapy with rituximab and mycophenolate mofetil in systemic sclerosis. A single-centre case series study.

Authors:  Paolo Fraticelli; Colomba Fischetti; Fausto Salaffi; Marina Carotti; Massimo Mattioli; Giovanni Pomponio; Armando Gabrielli
Journal:  Clin Exp Rheumatol       Date:  2018-09-30       Impact factor: 4.473

5.  2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative.

Authors:  Frank van den Hoogen; Dinesh Khanna; Jaap Fransen; Sindhu R Johnson; Murray Baron; Alan Tyndall; Marco Matucci-Cerinic; Raymond P Naden; Thomas A Medsger; Patricia E Carreira; Gabriela Riemekasten; Philip J Clements; Christopher P Denton; Oliver Distler; Yannick Allanore; Daniel E Furst; Armando Gabrielli; Maureen D Mayes; Jacob M van Laar; James R Seibold; Laszlo Czirjak; Virginia D Steen; Murat Inanc; Otylia Kowal-Bielecka; Ulf Müller-Ladner; Gabriele Valentini; Douglas J Veale; Madelon C Vonk; Ulrich A Walker; Lorinda Chung; David H Collier; Mary Ellen Csuka; Barri J Fessler; Serena Guiducci; Ariane Herrick; Vivien M Hsu; Sergio Jimenez; Bashar Kahaleh; Peter A Merkel; Stanislav Sierakowski; Richard M Silver; Robert W Simms; John Varga; Janet E Pope
Journal:  Ann Rheum Dis       Date:  2013-11       Impact factor: 19.103

Review 6.  Scleroderma renal crisis: a rare but severe complication of systemic sclerosis.

Authors:  Luc Mouthon; Alice Bérezné; Guillaume Bussone; Laure-Hélène Noël; Peter M Villiger; Loïc Guillevin
Journal:  Clin Rev Allergy Immunol       Date:  2011-04       Impact factor: 8.667

7.  Scleroderma renal crisis: poor outcome despite aggressive antihypertensive treatment.

Authors:  J G Walker; M J Ahern; M D Smith; M Coleman; K Pile; M Rischmueller; L Cleland; P J Roberts-Thomson
Journal:  Intern Med J       Date:  2003 May-Jun       Impact factor: 2.048

8.  Evolution of chronic kidney disease in patients with systemic lupus erythematosus over a long-period follow-up: a single-center inception cohort study.

Authors:  Elisheva Pokroy-Shapira; Ilana Gelernter; Yair Molad
Journal:  Clin Rheumatol       Date:  2014-02-19       Impact factor: 2.980

9.  Anti-neutrophil cytoplasmic antibody negative crescentic paucimmune glomerulonephritis in a case of scleroderma with systemic lupus erythematosus overlap.

Authors:  Rohit Tewari; Sonia Badwal; Arun Kumar; Shankar Subramaniam; V S Nijhawan; V Srinivas
Journal:  Saudi J Kidney Dis Transpl       Date:  2016-05

10.  Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis.

Authors:  Pia Moinzadeh; Elisabeth Aberer; Keihan Ahmadi-Simab; Norbert Blank; Joerg H W Distler; Gerhard Fierlbeck; Ekkehard Genth; Claudia Guenther; Ruediger Hein; Joerg Henes; Lena Herich; Ilka Herrgott; Ina Koetter; Alexander Kreuter; Thomas Krieg; Kathrin Kuhr; Hanns-Martin Lorenz; Florian Meier; Inga Melchers; Hartwig Mensing; Ulf Mueller-Ladner; Christiane Pfeiffer; Gabriela Riemekasten; Miklós Sárdy; Marc Schmalzing; Cord Sunderkoetter; Laura Susok; Ingo H Tarner; Peter Vaith; Margitta Worm; Gottfried Wozel; Gabriele Zeidler; Nicolas Hunzelmann
Journal:  Ann Rheum Dis       Date:  2014-01-03       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.